Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens
- Author
- SHUMACK, Stephen1 ; ROBINSON, June2 ; KOSSARD, Steven3 ; GOLITZ, Loren4 ; GREENWAY, Hubert5 ; SCHROETER, Arnold6 ; ANDRES, Kara7 ; AMIES, Mark8 ; OWENS, Mary7
[1] St George Hospital, Kogarah, Australia
[2] Loyola University Medical Center, Maywood, Ill, United States
[3] Skin and Cancer Foundation Australia, Darlinghurst, Australia
[4] Dermatopathology Services, LLC, Denver, Colo, United States
[5] Scripps Clinic, La Jolla, Calif, United States
[6] Mayo Clinic, Rochester, Minn, United States
[7] 3M Pharmaceuticals, St Paul, Minn, United States
[8] 3M Health Care, Thornleigh, United States - Source
Archives of dermatology (1960). 2002, Vol 138, Num 9, pp 1165-1171, 7 p ; ref : 40 ref
- CODEN
- ARDEAC
- ISSN
- 0003-987X
- Scientific domain
- Dermatology
- Publisher
- American Medical Association, Chicago, IL
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Carcinome basocellulaire Chimiothérapie Efficacité traitement Homme Imiquimod Immunomodulateur Modalité traitement Nodule Voie locale Peau pathologie Tumeur maligne
- Keyword (en)
- Antineoplastic agent Basal cell carcinoma Chemotherapy Treatment efficiency Human Imiquimod Immunomodulator Application method Nodule Local administration Skin disease Malignant tumor
- Keyword (es)
- Anticanceroso Carcinoma basocelular Quimioterapia Eficacia tratamiento Hombre Imiquimod Inmunomodulador Modalidad tratamiento Nódulo Vía local Piel patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R03 Immunotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13913071
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1001/archderm.138.9.1165 
https://dx.doi.org/10.1001/archderm.138.9.1165
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1001\/archderm.138.9.1165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:119:\"Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Archives of dermatology (1960)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Arch. dermatol. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"138\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1165\";s:8:\"\u0000*\u0000epage\";s:4:\"1171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-987X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SHUMACK\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Stephen\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:14:\"ROBINSON, June\";i:1;s:15:\"KOSSARD, Steven\";i:2;s:13:\"GOLITZ, Loren\";i:3;s:16:\"GREENWAY, Hubert\";i:4;s:17:\"SCHROETER, Arnold\";i:5;s:12:\"ANDRES, Kara\";i:6;s:11:\"AMIES, Mark\";i:7;s:11:\"OWENS, Mary\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARDEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:119:\"Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1001\/archderm.138.9.1165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:119:\"Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Archives of dermatology (1960)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Arch. dermatol. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"138\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1165\";s:8:\"\u0000*\u0000epage\";s:4:\"1171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-987X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SHUMACK\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Stephen\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:14:\"ROBINSON, June\";i:1;s:15:\"KOSSARD, Steven\";i:2;s:13:\"GOLITZ, Loren\";i:3;s:16:\"GREENWAY, Hubert\";i:4;s:17:\"SCHROETER, Arnold\";i:5;s:12:\"ANDRES, Kara\";i:6;s:11:\"AMIES, Mark\";i:7;s:11:\"OWENS, Mary\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARDEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:119:\"Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:27:\"10.1001\/archderm.138.9.1165\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1001\/archderm.138.9.1165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:119:\"Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Archives of dermatology (1960)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Arch. dermatol. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"138\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1165\";s:8:\"\u0000*\u0000epage\";s:4:\"1171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-987X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SHUMACK\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Stephen\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:14:\"ROBINSON, June\";i:1;s:15:\"KOSSARD, Steven\";i:2;s:13:\"GOLITZ, Loren\";i:3;s:16:\"GREENWAY, Hubert\";i:4;s:17:\"SCHROETER, Arnold\";i:5;s:12:\"ANDRES, Kara\";i:6;s:11:\"AMIES, Mark\";i:7;s:11:\"OWENS, Mary\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARDEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:119:\"Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1001\/archderm.138.9.1165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:119:\"Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Archives of dermatology (1960)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Arch. dermatol. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"138\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1165\";s:8:\"\u0000*\u0000epage\";s:4:\"1171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-987X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SHUMACK\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Stephen\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:14:\"ROBINSON, June\";i:1;s:15:\"KOSSARD, Steven\";i:2;s:13:\"GOLITZ, Loren\";i:3;s:16:\"GREENWAY, Hubert\";i:4;s:17:\"SCHROETER, Arnold\";i:5;s:12:\"ANDRES, Kara\";i:6;s:11:\"AMIES, Mark\";i:7;s:11:\"OWENS, Mary\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARDEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:119:\"Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1001\/archderm.138.9.1165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:119:\"Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Archives of dermatology (1960)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Arch. dermatol. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"138\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1165\";s:8:\"\u0000*\u0000epage\";s:4:\"1171\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-987X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"SHUMACK\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Stephen\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:14:\"ROBINSON, June\";i:1;s:15:\"KOSSARD, Steven\";i:2;s:13:\"GOLITZ, Loren\";i:3;s:16:\"GREENWAY, Hubert\";i:4;s:17:\"SCHROETER, Arnold\";i:5;s:12:\"ANDRES, Kara\";i:6;s:11:\"AMIES, Mark\";i:7;s:11:\"OWENS, Mary\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARDEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:119:\"Efficacy of Topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: Comparison of dosing regimens\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
